|
|
|
|
Vol. 12, Issue 4, 1147-1160, April 2001



and
*Department of Biochemistry and Molecular Biology,
Institute of Pathology, University of Southern Denmark,
Odense University, DK-5230 Odense M, Denmark;
Institute
of Biochemistry, Graz, University of Technology, A-8010 Graz, Austria;
and §German Cancer Research Center, 69120 Heidelberg,
Germany
| |
ABSTRACT |
|---|
|
|
|---|
Deletion of the yeast gene ACB1 encoding Acb1p, the
yeast homologue of the acyl-CoA-binding protein (ACBP), resulted in a slower growing phenotype that adapted into a faster growing phenotype with a frequency >1:105. A conditional knockout strain
(Y700pGAL1-ACB1) with the ACB1 gene under
control of the GAL1 promoter exhibited an altered
acyl-CoA profile with a threefold increase in the relative content of
C18:0-CoA, without affecting total acyl-CoA level as previously
reported for an adapted acb1
strain. Depletion
of Acb1p did not affect the general phospholipid pattern, the rate of
phospholipid synthesis, or the turnover of individual phospholipid
classes, indicating that Acb1p is not required for general glycerolipid
synthesis. In contrast, cells depleted for Acb1p showed a dramatically
reduced content of C26:0 in total fatty acids and the sphingolipid
synthesis was reduced by 50-70%. The reduced incorporation of
[3H]myo-inositol into
sphingolipids was due to a reduced incorporation into
inositol-phosphoceramide and mannose-inositol-phosphoceramide only, a pattern that is characteristic for cells with aberrant endoplasmic reticulum to Golgi transport. The plasma membrane of the
Acb1p-depleted strain contained increased levels of
inositol-phosphoceramide and
mannose-inositol-phosphoceramide and lysophospholipids.
Acb1p-depleted cells accumulated 50- to 60-nm vesicles and
autophagocytotic like bodies and showed strongly perturbed plasma
membrane structures. The present results strongly suggest that Acb1p
plays an important role in fatty acid elongation and membrane assembly
and organization.
| |
INTRODUCTION |
|---|
|
|
|---|
Acyl-CoA binding protein (ACBP) is an 86- to 92-residue protein
with a highly conserved sequence found in a wide range of species from
yeast and plants to reptiles, birds, and mammals (Kragelund et
al., 1996
). ACBP homologues can be grouped into four different
types: 1) a general basic form (l-ACBP), which is expressed in all
tissues in all tested eukaryotes (Kragelund et al., 1999
);
2) a testis-specific form (t-ACBP), called endozepin-like protein,
which has been shown to be present in spermatozoa only (Pusch et
al., 1996
); 3) a brain-specific form (Lihrmann et al., 1994
); and 4) a group of larger proteins, which contain an ACBP subdomain. The
3
2-enoyl-CoA
isomerase, which is essential for
-oxidation of unsaturated fatty
acids in mammalian peroxisomes, belongs to this group (Geisbrecht et al., 1999
). The Caenorhabditis elegans genome
contains six putative open reading frames with partial homologies to
ACBP. Bovine ACBP, rat l-ACBP, yeast ACBP, and ACBP from
Arabidopsis thaliana bind saturated and unsaturated
C14-C22-acyl-CoA esters with high specificity and affinity
(KD 1-15 nM; Rosendal et al., 1993
;
Faergeman et al., 1996
; Jens Knudsen, unpublished results). ACBP is unable to bind free fatty acids but binds CoA with a
KD of 1-2 µM (Robinson et al.,
1996
). The CoA head group thus plays a key role in mediating the
specificity for binding of acyl-CoA esters.
Long-chain acyl-CoA esters serve as important intermediates in fatty
acid elongation, lipid synthesis, and fatty acid degradation. In
addition to these functions, a large body of evidence indicates that
long-chain acyl-CoA esters also have important functions in the
regulation of intermediary metabolism and transcription (Færgeman and
Knudsen, 1997
). ACBP has been shown to protect acetyl-CoA carboxylase,
acyl-CoA synthetase, and adenylate translocase against inhibition by
long-chain acyl-CoA esters in vitro (Rasmussen et al.,
1993
). ACBP mediates intermembrane acyl-CoA transport and protects
long-chain acyl-CoA esters from being hydrolyzed by cellular acyl-CoA
hydrolases (Færgeman and Knudsen, 1997
). The observation that ACBP can
facilitate transport of acyl-CoA between membranes in vitro combined
with the fact that overexpression of bovine ACBP in yeast increases the
intracellular acyl-CoA pool strongly suggest that ACBP acts as an
acyl-CoA transporter and pool former in vivo.
Long-chain acyl-CoA esters have been shown to be required for fission
and fusion of COPI-coated vesicles (Glick and Rothman, 1987
;
Pfanner et al., 1989
, 1990
; Rothman and Wieland, 1996
). Long-chain acyl-CoA esters are also a requisite for the endophilin and
CtBP/BARS catalyzed acylation of lysophosphatidic acid (LPA), which is required for the formation of endocytic vesicles and for
fission of Golgi membranes, respectively (Schmidt et al., 1999
; Weigert et al., 1999
).
In the present work we show that yeast cells carrying a deletion in the ACB1 gene are extremely unstable and revert into a faster growing "adapted" variant with a frequency >1:105. To circumvent the adaptation problem, we constructed a conditionally Acb1p-depleted strain, in which ACB1 is under the regulation of the glucose-repressible GAL1-promoter (Y700pGAL1-ACB1). Under repressing glucose conditions, Y700pGAL1-ACB1 exhibits reduced growth rate on synthetic medium, changes in acyl-CoA chain length profile, and strongly reduced synthesis of very long-chain fatty acids (VLCFA) and sphingolipids. Under these growth conditions, this strain accumulates 50- to 60-nm vesicles, autophagocytotic-like bodies, and bundles of unidentified fibrous material closely associated with the plasma membrane. These results indicate that abrogated intracellular transport of de novo synthesized acyl-CoA esters in Y700pGAL1ACB1 strongly affects membrane structure and organization in vivo.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Yeast Strains and Culture Media
The Saccharomyces cerevisiae strain used was Y700: MATa, ade2-1 trp1 can1-100 leu2-3 leu2-112 his3-11 his3-15 ura3, a haploid derivative of W303.
Yeast strains were cultivated at 30°C in minimal YNB medium (8 g/l yeast nitrogen base without amino acids [with or without inositol], 55 mg/l adenine, 55 mg/l tyrosine) containing the amino acid mixture and uracil in a 7× concentration. Acb1p-depleted cells used for experiments were maintained on 2% galactose plates. When needed, a colony was picked and diluted to OD 0.005 and grown for 24 h in glucose medium, diluted to OD 0.1 into fresh glucose medium, and grown to the optical density indicated. Where indicated, the cells were supplemented with either 500 µM fatty acid/0.05% Brij58 or 25 µM phytosphingosine (PHS) when diluted into fresh media. If nothing else is stated, cells were kept on YP-galactose plates (2%) and inoculated in YNB medium supplemented with 2% glucose to an OD600 of 0.005. Cells were grown for 24 h, diluted into fresh medium to an OD600 of 0.05-0.1, and grown to the OD600 indicated.
Genetic Manipulations
Disruption of ACB1 was performed by the one-step gene
disruption technique (Rothstein, 1983
). The 195-bp
HindII-BclI fragment of pACB1cer Dbg950 (Borsting
et al., 1997
) was replaced with the 3.5-kb pair
ScaI-BamHI fragment covering the LEU2
gene from the plasmid pRS305 (kindly provided by R. Rothstein). A
3.9-kb pair NheI/AvaI fragment containing the
disrupted ACB1 gene was isolated and used for
ACB1 disruption. The plasmid
pFA6a-kanMX4-promGAL1 (Wach et al., 1994
)
containing the kanMX4 resistance marker and the GAL1
promoter was used as a template for polymerase chain reaction (PCR) to
amplify the replacement fragment. A pair of oligonucleotide hybrid
oligonucleotides (upstream oligo:
CTAAAACTCTAAAATTAGTTAAACTAGTGTTTTCAGCAA AATCGATGAATTCGAGCTCG; downstream oligo: CGTTGACG-GCTTTAGCTTTTTCTTCGAATAATTGGGAAACCATGGATCCG -GGGTTTTTTCTCCT, where the underlined
sequences indicate homology to the KanMX4 gene) containing 40 nucleotides homologous to the upstream region or to the first 40 nucleotides of the coding region of ACB1 and 18-19
nucleotides homologous to pFA6a-kanMX4-promGAL1, was used.
The 40 nucleotides homologous to the upstream region of ACB1
were located immediately upstream of the start codon. PCR fragments of
~1.65 kb, harboring the kanMX4 marker and the GAL1
promoter and flanking sequences, were generated, using standard techniques with ~50 ng of the NotI fragment of
pFA6a-kanMX4-promGAL1 as a template. Y700 was rendered
competent using lithium acetate as described by Gietz et
al. (1992)
. Transformants were selected on YP plates
supplemented with 2% galactose and 200 µg/ml G418.
Extraction and Analysis of Fatty Acids and Acyl-CoAs
Growth was stopped by addition of 0.1 volume of chilled 6.6 M perchloric acid and crushed ice directly to the medium. Cells (4 × 109) were harvested and washed once with 10 mM perchloric acid. The supernatant was removed and 100-150 µg C15:0 fatty acid and 1 nmol C17:0-CoA were added as internal standards. The volume was adjusted to 250 µl, and 1 g of glass beads was added. The mixture was shaken at 0°C until cells were broken as determined by microscopy. H2O (0.5 ml) and chloroform:methanol (2:1, 3 ml) were added and mixed. An additional 1 ml of chloroform and 1 ml of H2O were added and mixed again. The mixture was centrifuged to separate the phases. The lower phase containing the fatty acids was dried under nitrogen. The lipids were hydrolyzed with 0.4 ml of 0.5 M NaOH in methanol at 100°C overnight and methylated with BF3. The methyl esters were separated on a Chrompak CP-CIL 88 capillary column (Chrompack, Middelburg, the Netherlands) using hydrogen as a carrier gas and a temperature gradient from 145 to 220°C (10°C/min). The acyl-CoA-containing interphase from the lipid extraction was dried under nitrogen. 2-(N-morpholino)ethanesulfonic acid (0.7 ml of 100 mM, pH 6.5) containing 0.7 mg of recombinant ACBP was added. The acyl-CoA esters were extracted by shaking for 90 min at 4°C and analyzed by high performance liquid chromatography. The recovery of radioactive C16:0-CoA added together with the C17:0-CoA internal standard was >75%.
Samples were loaded onto a small ODS 10/100 precolumn equilibrated with 20% acetonitrile in 20 mM KH2PO4, pH 5.3, and washed for 5 min. The acyl-CoA esters were then eluted in reversed manner on an ODS 10/100 column (4.6 × 250 mm) by the following gradient of solvent B (70% acetonitrile in 20 mM KH2PO4, pH 5.3) in solvent A (30% acetonitrile in 20 mM KH2PO4, pH 5.3): 15-25% for 25 min, 25-45% for 20 min, 45-65% for 10 min, 65-90% for 6 min, and 90% for 9 min. The flow was 1.0 ml/min.
Phospholipid (PL) Analysis
Determination of steady-state PL composition was done
essentially as described by Patton-Vogt et al. (1997)
. Cells
were grown in low phosphate synthetic medium containing 10 µCi
[32P]Pi/ml for six to
seven generations. Lipids were extracted, and individual PLs were
resolved by two-dimensional thin-layer chromatography (TLC), using
chloroform:methanol:ammonium hydroxide (65:35:7) for the first
dimension and chloroform:acetone:methanol:acetic acid:H2O (10:4:2:2:1) for the second dimension.
The plates were scanned on a STORM Phosphor Imager 840 (Molecular
Dynamics, Sunnyvale, CA), and spots were quantified using
ImageQuant software (Amersham-Pharmacia Biotech, Uppsala, Sweden).
Mass Spectroscopic Analysis of Plasma Membrane Lipids
Plasma membranes were isolated following the procedure described
by Serrano (1988)
. Lipids were extracted and analyzed by mass
spectroscopy on a Quattro II (Micromass, Manchester, United Kingdom) as
previously described (Schneiter et al., 1999
).
Protein Extraction and Western Blotting
Cells were lysed with 0.5 ml of 0.2 M NaOH, 0.2%
-mercaptoethanol for 10 min on ice. Proteins were precipitated with
5% trichloroacetic acid. The pellets were dissolved in 70 µl of 2 volumes of SDS-sample buffer (2×) and 1 volume of 1 M Tris base,
heated at 95°C for 10 min, and subjected to 10% SDS-PAGE. Proteins
were blotted onto a nitrocellulose membrane (KEM EN TEC,
Copenhagen, Denmark) and detected using the enhanced chemiluminescence
as described by the manufacturer (Amersham-Pharmacia Biotech, Uppsala, Sweden).
Determination of Acb1p Acyl-CoA-Binding Specificity by Isoelectric Focusing
Isoelectric focusing analysis was performed on a Pharmacia Phast
System using pH 3-9 as recommended by the manufacturer. Acyl-CoA esters were synthesized as previously described (Knudsen, 1979
). All
ligands were in threefold molar excess to yeast ACBP (1 mg/ml).
RNA Preparation
The cells were immediately cooled by addition of 1 volume of
ice, pelleted, and washed with ice-cold water. Total RNA was extracted
by the hot phenol method, immediately dissolved in freshly deionized
formamide, and stored at
80°C.
Northern Blotting
Total RNA (10 µg/lane) was separated on 1% (wt/vol)
denaturing agarose gel and transferred to a ZetaProbe GT positive nylon membrane (Bio-Rad, Hercules, CA). Reverse transcription-PCR-generated probes were labeled with [32P]dCTP using an
oligolabeling kit (Pharmacia Biotech). The three ELO probes
were checked for specificity with three corresponding knockout strains
(kindly provided by C.E. Martin (elo1
) and G. Loison
(elo2
/fen1
and
elo3
/sur4
)).
Labeling of Total Cellular Sphingolipids with [3H]myo-Inositol
For steady-state labeling cells were grown from OD 0.1 to 0.5 in 3 ml of YNB medium containing 11 µM inositol and 30 µCi [3H]myo-inositol (NEN Life Science Products, Boston, MA). For pulse labeling, 40 OD600 units of cells were pulsed with 4 µCi [3H]myo-inositol per OD in inositol-free medium at OD 10 for 15 min and chased for 5 h.
At the indicated time, the OD600 was determined, 1 ml of each of the cultures was chilled on ice, and 5-6 OD units of unlabeled stationary phase cells were added as carrier. The cells were harvested, washed twice with ice-cold H2O, and resuspended in 5% trichloroacetic acid at 4°C for 20 min. Glass beads (0.5 ml, 425-600 µm) were added, lipids were extracted twice for 30 min at 60°C with 1 ml of ethanol:water:diethyl ether:pyridine:ammonium hydroxide (15:15:5:1:0.018) on a thermomixer at 1400 rpm, extracts were pooled, and the solvent was evaporated. Lipids were dissolved in chloroform:methanol:water (16:16:5), and 3H activity was determined by scintillation counting of 10 µl. Mild saponification was performed with 1 ml of 0.2 M NaOH in methanol at 30°C for 1 h. EDTA (1 ml 0.5 M) was added, the solution was acidified with 200 µl of 1 M acetic acid, and unsaponified lipids were extracted with 1 ml of chloroform. The extracts were dried, the sphingolipids were redissolved in 30 µl of chloroform:methanol (1:1), and incorporated [3H]myo-inositol was quantified by scintillation counting. Individual lipid species were separated by high-performance TLC (HPTLC) using chloroform:methanol:4.2 M ammonium hydroxide (9:7:2) as the developing solvent. HPTLC plates were scanned on an Automatic TLC-Linear Analyzer Tracemaster 20 (Berthold, Nashua, NH).
Spheroplast Rate Assay
Cells were harvested, washed three times in deionized water, and resuspended to OD 0.5 in Tris-EDTA buffer (pH 7.3) at 25°C. Freshly prepared Zymolyase 20T (25 µl of 2 mg/ml; Seikagaku, Tokyo, Japan) was added and OD600 was determined as indicated.
[3H]myo-Inositol and [3H]Serine Uptake Assay
The cells were diluted in fresh inositol medium (with or without palmitic acid) to an OD600 of 0.1 and grown to OD600 0.5. Cells were then washed three times with phosphate-buffered saline (PBS) and resuspended in PBS (30°C) to OD 1.0. Cells (1 ml) were incubated at 30°C for 5 min, and then 10 µCi [3H]myo-inositol (NEN Life Science Products, Madison, WI) was added. Incubation was continued with gentle shaking. Samples (200 µl) were collected and transferred to a stop solution on ice (1 ml of ice-cold PBS containing 90 µg of inositol/ml) after 1, 4, 7, and 10 min. Cells were collected on GF/C glass microfiber paper (Whatman Tewksbury, MA), washed three times with ice-cold PBS, and air-dried. [3H]myo-inositol uptake was determined using a STORM Phosphor Imager 840 (Molecular Dynamics). Serine uptake was assayed and quantified in a similar manner using 20 µCi [3H]serine (NEN Life Science Products, Boston, MA) and 10 mM serine in the stop buffer.
Electron Microscopy
Electron microscopy was performed as described by Kaiser and
Schekman (1990)
.
| |
RESULTS |
|---|
|
|
|---|
Construction of Y700pGAL1-ACB1, a Conditional Y700acb1
Strain
We have previously shown that disruption of the
ACB1 gene in three different strains of the yeast S. cerevisiae had no effect on the growth rate on YNB-glucose medium
(Schjerling et al., 1996
; Gaigg, Neergaard, Schneiter,
Hansen, Færgeman, Jensen, Andersen, Friis, Sandhoff, Schrøder, and
Knudsen, unpublished results). In contrast, Choi et al.
(1996)
showed that disruption of ACB1 in the wild-type
strain DTY10A resulted in retardation of growth compared with wild
type. The variable phenotype of acb1 null mutant cells could
indicate that different genetic backgrounds respond differently to the
lack of Acb1p or that the acb1
strains are unstable and
undergo adaptational changes, which enables them to grow faster. A
diploid ACB1/acb1
strain always segregated into two big
and two small colonies (with and without the ACB1 gene,
respectively, as confirmed by PCR, Gaigg, Neergaard, Schneiter, Hansen,
Færgeman, Jensen, Andersen, Friis, Sandhoff, Schrøder, and Knudsen,
unpublished results). When an original acb1
colony from a
transformation or from a tetrad analysis was resuspended and plated on
YNB-glucose medium, 1 of 10,000 colonies were significantly larger,
i.e., adapted into a faster growing phenotype. Small colonies from this
plate, grown in liquid YNB-glucose medium, showed an adaptation
frequency of 1:104 to 1:10.
The high adaptation rate of Y700acb1
made this strain
unsuitable to study the physiological function of Acb1p. To construct a
condition knockout, we inserted the GAL1 promoter directly
in front of ACB1 without deleting anything of the original
promoter of ACB1 to avoid interference with the expression
of ORM1, a gene of ~700 bp upstream of ACB1,
sharing promoter region with ACB1. Northern blotting
analysis confirmed that Y700 and Y700pGAL1-ACB1 express identical levels of ORM1 mRNA when grown in YNBD
medium with and without 500 µM palmitic acid added, although addition of fatty acids increased ORM1 mRNA expression 1.7 in both
wild-type and the Acb1p-depleted cells (Gaigg, Neergaard, Schneiter,
Hansen, Færgeman, Jensen, Andersen, Friis, Sandhoff, Schrøder, and
Knudsen, unpublished results). We therefore conclude that Orm1p
expression is not affected by depletion of Acb1p
inY700pGAL1-ACB1.
When a single colony from a galactose plate was grown in media
supplemented with 2% galactose for 36 h, Y700 and
Y700pGAL1-ACB1 grew with the same generation time (Figure
1A). However, when the 36-h galactose
culture was diluted to OD 0.005 in 2% glucose medium and grown to late
logarithmic phase at 30°C, Y700pGAL1-ACB1 exhibited
reduced growth rate and never reached wild-type OD after 24 h
(Figure 1B). In galactose media, levels of Acb1p were increased ~10-fold in the Y700pGAL1-ACB1 strain compared with
wild-type cells (Figure 1, C and D). Acb1p levels in
Y700pGAL1-ACB1 declined very rapidly when cells were shifted
to glucose medium (Figure 1C). Acb1p could no longer be detected by
Northern blot or Western blot analysis, after growth under repressing
glucose conditions for 24 h. If growth were continued, however,
Acb1p reappeared at low levels after 36 h (Figure 1C). This is
likely to be due to loss of repression by glucose in cultures that have
past the diauxic shift. Cells used in all the following experiments
were maintained on 2% galactose plates. When needed, a colony was
picked and diluted to OD 0.005 and grown for 24 h in glucose
medium, diluted to OD 0.1 in fresh glucose medium, and grown to the
indicated optical density. Where indicated, the medium was supplemented with either 500 µM fatty acid/0.05% Brij58 or 25 µM PHS in the final culture subsequent to dilution of the overnight glucose culture.
After each experiment, the absence of Acb1p was verified by Western
blot analysis.
|
Acb1p Is Required for Fatty Acid Elongation but Not for General Glycerolipid Synthesis
The level of total acyl-CoA in Y700pGAL1-ACB1 cells
grown under repressing conditions was identical to that of wild type. However, the relative content of stearoyl-CoA in
Y700pGAL1-ACB1 cells was increased 3.5-fold and that of
unsaturated acyl-CoA was reduced 2- to 2.5-fold (Figure
2A). The relative content of C16:0-CoA
remained unchanged. A similar increase in the relative amount of
C18:0-CoA was previously observed in an adapted Y700acb1
strain (Schjerling et al., 1996
).
|
We have previously shown that overexpression of Acb1p in yeast results
in a twofold increase in the total level of acyl-CoA esters (Knudsen
et al. 1994
). Remarkably, the 10-fold increased level of
Acb1p in galactose-cultivated Y700pGAL1-ACB1 cells did not
affect fatty acid composition compared with wild type (Gaigg, Neergaard, Schneiter, Hansen, Færgeman, Jensen, Andersen, Friis, Sandhoff, Schrøder, and Knudsen, unpublished results). However, under
repressing conditions dramatic changes in the fatty acid pattern were
observed. The total content of fatty acids per
OD600 unit was reduced to ~70% of wild type
and the content of C26:0 fatty acid was reduced by ~70% (Figure 2B).
The relative content of unsaturated fatty acids was increased by
~7%, and the ratio of C16:1 to C18:1 was increased by a factor of
1.6. A reduction in C26:0 synthesis was also observed in the adapted
knock out strain in early logarithmic phase but disappeared when the
cells reached stationary phase (Gaigg, Neergaard, Schneiter, Hansen, Færgeman, Jensen, Andersen, Friis, Sandhoff, Schrøder, and Knudsen, unpublished results). Fatty acid synthesis in yeast is terminated by
the malonyl-CoA/palmitoyl-CoA transferase forming acyl-CoA as the end
product, and the longest fatty acyl-CoA to be synthesized by this
pathway is C18:0-CoA (Sumper and Trauble, 1973
). The accumulation of
fatty acid synthase end product C18:0-CoA and the simultaneously reduced elongation to C26:0 suggests that Acb1p is required for termination of fatty acid synthesis and transport of acyl-CoAs to the
elongation systems.
When Y700 and Y700pGAL1-ACB1 cells were grown to OD 0.2-0.5 in the presence or absence of 500 µM palmitic acid, the content of C26:0 was ~0.50% of the total fatty acids in Y700 and 0.22% in Y700pGAL1-ACB1. Despite a large increase in the level of C16-CoA upon supplementation with palmitic acid (Gaigg, Neergaard, Schneiter, Hansen, Færgeman, Jensen, Andersen, Friis, Sandhoff, Schrøder, and Knudsen, unpublished results), palmitic acid supplementation did not rescue C26:0 synthesis in Y700pGAL1-ACB1, indicating that elongation of both de novo synthesized and exogenously added C16:0 depend on Acb1p.
Because Acb1p binds long-chain acyl-CoA esters, loss of Acb1p function
might be expected to affect glycerolipid synthesis. To examine PL
synthesis in the Acb1p-depleted strain, cells were labeled with
[32P]Pi for six to seven
generations, and the steady-state composition of PLs (Figure
3) and the turnover of the different PL
classes were determined. The pattern of 32P
incorporation under steady-state labeling revealed that PL composition in the Y700pGAL1-ACB1 was comparable to that of wild-type
cells.
|
Calculation of turnover of individual PL classes from 32P-pulse/chase experiments revealed that the half-life of phosphatidyl ethanolamine (PE), phosphatidyl serine (PS), and phosphatidyl inositol (PI) were very similar in the two strains 3.3 and 3.9, 2.8 and 2.8, and 5.3 and 5.1 h for the Y700 and Y700pGAL1-ACB1, respectively. Phosphatidyl choline (PC) turnover was slightly reduced in the Acbp1-depleted strain with a half-life of 5.6 h compared with 4.6 h in Y700. Synthesis of total and individual PL classes was also examined by [1-14C]acetate pulse labeling. [1-14C]acetate was added to exponentially growing cells (OD 0.5) cultured in glucose media. After 15 min, cells were harvested, and lipids were extracted and analyzed by TLC. Both strains incorporated similar amounts of [1-14C]acetate. The TLC analysis revealed a pattern of incorporation into both neutral lipids and all major PL classes, which was identical in the two strains (Gaigg, Neergaard, Schneiter, Hansen, Færgeman, Jensen, Andersen, Friis, Sandhoff, Schrøder, and Knudsen, unpublished results). To our surprise, the results indicate that Acb1p is not required for general glycerolipid synthesis.
Acb1p Depletion Affects Expression of Genes Involved in Fatty Acid Desaturation But Not Elongation
To investigate the reason for reduced fatty acid elongation and
increased fatty acid unsaturation in the Acb1p-depleted strain, we
analyzed the expression levels of gene products involved in these
processes. We and others have shown that OLE1 mRNA was
increased 3- and 5.5-fold in the adapted Y700acb1
and in
JY001acb1
, respectively (Choi et al., 1996
;
Schjerling et al., 1996
). The increased expression of
OLE1 was confirmed in glucose-grown
Y700pGAL1-ACB1 cells in which the level of OLE1
mRNA was increased fivefold (Gaigg, Neergaard, Schneiter, Hansen,
Færgeman, Jensen, Andersen, Friis, Sandhoff, Schrøder, and Knudsen,
unpublished results). The higher proportion of unsaturated fatty acids
in Y700pGAL1-ACB1 might therefore be caused by the increase
in
-9-desaturase activity. In the yeast S. cerevisiae,
three membrane-bound enzymes, Elo1/2/3p, catalyze elongation of fatty
acids. Elo1p is involved in elongation of C14:0-fatty acid to C16:0
(Toke and Martin, 1996
). Elo2/3p acts downstream of Elo1p and catalyzes
the elongation of fatty acids to C24:0 and C26:0, respectively (Oh
et al., 1997
). The mRNA levels of all three fatty acid
elongation enzymes were unchanged in Y700pGAL1-ACB1 cells
grown under glucose-repressing conditions (Gaigg, Neergaard, Schneiter,
Hansen, Færgeman, Jensen, Andersen, Friis, Sandhoff, Schrøder, and
Knudsen, unpublished results). The requirement of Acb1p in fatty acid
elongation could be at three different levels. Transport of de novo
synthesized acyl-CoA esters from the fatty acid syntase to the
elongases, shuttling of acyl-CoA intermediates between the individual
elongases or removal of the final acyl-CoA product. Acb1p has been
shown to bind C16:0-CoA with a KD of 2.3 nM (Fulceri
et al., 1997
). Because binding of negatively charged acyl-CoA to Acb1p changes the isoelectric point, we used isoelectric focusing to determine the relative binding affinities of long-chain and
very long-chain acyl-CoA esters to yeast Acb1p. From Figure 4 it can be seen that C16:0-, C18:0-, and
C20:0-CoA esters shift the isoelectric point of Acb1p, whereas
C22:0-CoA is less efficient. In contrast, C24:0-CoA is unable to bind
to Acb1p and does not shift its isoelectric point. It is therefore
unlikely that Acb1p is required for either shuttling of VLCFA-CoAs
between elongases or removal of the elongation product. The above
results rather suggest that Acb1p is involved in transport of long
chain acyl-CoA to the elongases.
|
Depletion of Acb1p Affects Sphingolipid Synthesis
Inositol-phosphoceramide (IPC), mannose-IPC (MIPC), and
mannose-(inositol-P)2-ceramide
(M(IP)2C) are the three major classes of
sphingolipids in S. cerevisiae. Sphingolipids, which
previously have been reported to comprise ~7-8% of the plasma
membrane mass and 30% of the plasma membrane lipids, respectively
(Patton and Lester, 1991
, 1992
), contain almost exclusively
C26:0 and hydroxy-C26:0 fatty acids in their hydrophobic ceramide
moiety (Lester et al., 1993
). Because of the pronounced
reduction in the level of C26:0 fatty acid, we examined whether
depletion of Acb1p affects the synthesis of complex lipids.
Therefore, Y700 and Y700pGAL1-ACB1 cells were grown for 6-7 h (steady state) in the presence of radiolabeled [3H]myo-inositol in a medium containing 11 µM inositol.
Radiolabeling of total lipids in Y700pGAL1-ACB1 was only
50% of the labeling in Y700. In wild-type cells and in
Y700pGAL1-ACB1 cells, 3.5 and 2%of the total
lipid-extractable radioactivity, respectively, was found in
sphingolipids (Figure 5B). Remarkably, the low [3H]myo-inositol
radioactivity incorporated into sphingolipids in Y700pGAL1-ACB1 was solely due to a reduced incorporation
into IPC and MIPC. Incorporation into M(IP)2C was
slightly increased in Y700pGAL1-ACB1 cells compared with
wild type.
|
Supplementation with 500 µM palmitic acid/0.05% Brij 58 in the incubation medium, of the final culture, restored the relative incorporation of [3H]inositol into individual inositol-sphingolipid species (Figure 5B) and increased total [3H]inositol incorporation into sphingolipids.
To examine the reduction in inositol incorporation in the
Acb1p-depleted strain in more detail, Y700pGAL1-ACB1 and
Y700 cells were pulse labeled in inositol-free medium at high
cell density (OD 10) to ensure momentarily and complete uptake of
[3H]inositol. After pulse labeling the
cells were chased by addition of a large volume of fresh medium
containing unlabeled inositol. No difference was observed in
[3H]myo-inositol
incorporation in PI during the pulse or in PI turnover during the
chase, between wild type and Y700pGAL1-ACB1 in either the
absence or presence of palmitic acid (Figure
6A). These data thus confirm the results
obtained by [32P]- and
[1-14C]acetate labeling and are consistent with
the fact that depletion of Acb1p does not affect the synthesis of
glycerophospholipids. However, Y700pGAL1-ACB1 displayed a
strongly reduced initial incorporation of
[3H]myo-inositol into
sphingolipids (30% of wild type), and transfer of
[3H]inositol from PI to sphingolipids
during chase was delayed. The reduced slope of the descending part of
the sphingolipid labeling curves (Figure 6B) suggests that the
Y700pGAL1-ACB1 strain also exhibits delayed turnover of
sphingolipids compared with wild-type cells. Again, the steady-state
labeling medium contained inositol, and the reduction in
sphingolipid labeling was solely due to a reduction in IPC and MIPC
labeling, whereas
[3H]myo-inositol
incorporation into M(IP)2C was unchanged (Gaigg, Neergaard, Schneiter, Hansen, Færgeman, Jensen, Andersen, Friis, Sandhoff, Schrøder, and Knudsen, unpublished results).
|
Plasma Membrane IPC and MIPC Levels Are Increased in the Acb1p-depleted Strain
If reduced
[3H]myo-inositol
incorporation into IPC was caused by decreased synthesis of this lipid,
it would be expected that Y700pGAL1-ACB1 contained less
inositol-sphingolipid in the plasma membrane. Mass
spectrometric analysis of plasma membrane phospho- and sphingolipid
species revealed that the level and pattern of individual PI species
were comparable to wild type in the Acb1p-depleted strain (Figure
7). Surprisingly, however, this analysis
revealed that the relative levels of IPC and MIPC were 25-40%
increased in Y700pGAL1-ACB1 compared with Y700. The pattern
of individual IPC and MIPC species, however, was comparable in the two
strains. The two major species were IPC/C containing PHS with 18 carbons and a C26OH fatty acid and IPC/B or IPC/B' containing
phytospingosine C18 and a C26 fatty acid or dihydrosphingosine C18 and
a C26OH fatty acid, respectively.
|
It is interesting to note that the relative level of IPC and MIPC is increased, although the incorporation of [3H]myo-inositol into these two species is strongly reduced in the Acb1p-depleted strain. This may indicate that the decreased labeling of these two lipids is due to a decreased turnover. This hypothesis is supported by the fact that sphingolipid turnover in Y700pGAL1-ACB1 is decreased compared with wild type (Figure 6B).
The mass spectroscopic analysis also revealed that the relative levels
of LPA, lysophosphatidylserine and lysophosphatidylinositol were
significantly increased in Y700pGAL1-ACB1 compared with Y700 (Table
1), indicating a lack of acyl-CoA for
acylation of lysophospholipids in remodeling of PLs at the plasma
membrane.
|
The increased level of LPA was caused by an increase in the unsaturated
LPA species only (Table 2) and was
accompanied by a large decrease in the content of
C16:1/C18:1-phosphatidic acid (PA). This may indicate that Acb1p is
required for delivery of C16:1- or C18:1-acyl-CoA for synthesis of this
particular PA species in the plasma membrane.
|
Genetic Interaction between lcb1 and GAL1-ACB1
Both acyl-CoA entry points in the sphingolipid synthesis pathway could potentially be affected by depletion of Acb1p (Figure 5A): Delivery of palmitoyl-CoA to Lcb1p/Lcb2p, which catalyzes the initial step of PHS synthesis, could be reduced. Alternatively, reduced delivery of VLCF-acyl-CoAs to the ceramide synthase could be the step affected.
Addition of 500 µM palmitic acid/0.05% Brij 58 to the medium used for growing Y700pGAL1-ACB1 for pulse labeling increased [3H]myo-inositol incorporation into sphingolipids to ~70% of wild-type level by increasing incorporation into IPC and MIPC (Figure 5B) but never restored sphingolipid synthesis completely. Addition of PHS did not affect total [3H]myo-inositol incorporation into sphingolipids or the incorporation pattern into individual sphingolipid species in Y700pGAL1-ACB1.
Tetrad analysis of a diploid strain made by mating
Y700pGAL1-ACB1 and the temperature-sensitive lcb1 mutant
(lcb1-100; Sutterlin et al., 1997
) showed that
the acb1 lcb1 double mutant spores grew extremely slowly at
permissive temperature (Figure 8). This
indicates that PHS synthesis is partly reduced in
Y700pGAL1-ACB1, although it is not rate limiting for
sphingolipid synthesis. The reduced PHS synthesis becomes visible only
when both mutations occur at the same time, consistent with the notion
that both mutations affect the same pathway, namely, synthesis of PHS.
|
The altered pattern of
[3H]myo-inositol
incorporation into sphingolipids in Y700pGAL1-ACB1 is
different from what would be expected if sphingolipid synthesis was
reduced because of lack of VLCFA synthesis (Oh et al.,
1997
). No genetic interaction could be observed by crossing elongase
mutants with acb1
(Gaigg, Neergaard, Schneiter, Hansen,
Færgeman, Jensen, Andersen, Friis, Sandhoff, Schrøder, and Knudsen,
unpublished results).
The [3H]myo-inositol
incorporation pattern observed in the Acb1p-depleted strain resembled
the pattern observed when sphingolipid synthesis is abrogated because
of inhibition of Golgi function by brefeldin A (BFA; Hechtberger and
Daum, 1995
). This fact may indicate that the altered sphingolipid
synthesis in the Acb1p-depleted strain is due to impaired vesicular
trafficking or membrane organization. To investigate this phenomenon
further, we analyzed the organelle and membrane structure by electron microscopy.
Cells Depleted of Acb1p Display Aberrant Membrane Profiles
The level of Acb1p in Y700pGAL1-ACB1 cells grown in
galactose medium is 8- to 10-fold higher than that of wild type (Figure 1). This increased level of Acb1p in Y700pGAL1-ACB1 did not
affect membrane morphology of this strain compared with wild type grown on galactose (Figure 9, a
and b). In contrast, cells depleted of
Acb1p accumulated a large number of variably sized vesicles and
granules (Figure 9c, arrows), and many cells also showed multilayer plasma membrane domains (Figure 9, c and f, fancy arrows). A large number of cells contained what could be interpreted as autophagocytotic like bodies (Figure 9, c and d, arrowheads) and randomly organized dense membrane areas (Figure 9d, star). Vacuolar inclusions of vesicles
containing autophagocytotic like bodies were observed frequently
(Figure 9e, arrows). Some cells exhibiting multilayer plasma membrane
domains also showed large invaginations of the plasma membrane and
accumulation of membrane material in the cytosol (Figure 9f,
arrowhead). In some cases, we observed a large amount of membrane
material within the vacuole, which could result from engulfment of the
plasma membrane invaginations (Figure 9, g and f). None of these
structures were observed in wild-type cells grown under identical
conditions (Figure 9h). These results indicate very strongly that
depletion of Acb1p affects vesicular trafficking, membrane biogenesis,
and the structure of the plasma membrane.
|
Y700pGAL1-ACB1 Exhibits Altered Cell Wall and Plasma Membrane Properties
A defect in vesicular trafficking and an altered plasma membrane
structure and lipid composition is likely to affect the integrity of
the yeast cell wall and transport across the plasma membrane. In yeast,
inositol is taken up by two transporters, ITR1 and
ITR2, of which one (ITR1) is repressed by
inositol in the medium (Nikawa et al., 1993
). We
therefore investigated inositol uptake in cells pregrown in
either the presence of inositol in the medium. Inositol uptake was strongly reduced in Y700pGAL1-ACB1 independently
of the presence of inositol in the medium during the culturing
(Figure 10A). These results differ from
what would be expected from the [3H]myo-inositol pulse
labeling of inositol-containing lipids (Figure 6B). In this
experiment, the labeling of PI was similar in Y700 and
Y700pGAL1-ACB1. This difference is most likely caused by the high cell density (10 OD unit/ml) present in the pulse-chase experiment compared with the uptake experiment (1 OD unit/ml), which ensures complete uptake of the very small amount of inositol added
during the 5-min pulse. The fact that uptake of
[3H]serine was also strongly reduced in
Y700pGAL1-ACB1 (Figure 10B) indicates that uptake of
nutrients from the medium by active transport is a general defect of
cells depleted of Acb1p. Addition of 500 µM palmitic acid to the
medium as described above partly restored inositol uptake and
restored serine uptake completely (Figure 10). In addition to the
decreased inositol uptake in cells depleted of Acb1p, these
cells also exhibited an Opi
phenotype and
excreted inositol (Gaigg, Neergaard, Schneiter, Hansen,
Færgeman, Jensen, Andersen, Friis, Sandhoff, Schrøder, and Knudsen,
unpublished results). The altered membrane and cell wall properties of
cells depleted of Acb1p were further explored by testing their
sensitivity to various detergents. When grown in glucose medium in the
presence of different concentrations of the detergent Brij58,
Y700pGAL1-ACB1 was severely inhibited by increasing
concentrations of Brij58 in the medium, whereas wild-type cells were
only slightly affected (Figure 11A).
Addition of fatty acids to the medium restored growth of
Y700pGAL1-ACB1 in the presence of all concentrations of
Brij58 (Figure 11A).
|
|
Susceptibility of S. cerevisiae to lysis by
glucanase-protease mixtures is a qualitative assay to test the state of
cell walls (Ovalle et al., 1998
). Cells depleted of Acb1p
were hypersensitive to Zymolyase treatment and displayed a total lack
of lag time characteristically observed in wild-type cells (Figure
11B).
| |
DISCUSSION |
|---|
|
|
|---|
The presented results suggest a specific role for Acb1p in
synthesis of VLCFA and membrane lipid turnover and trafficking. The
composition of the long-chain acyl-CoA in the Acb1p-depleted strain was
dramatically changed without any change in pool size. The relative
amount of C18:0-acyl-CoA is increased 3.5-fold with a compensatory
decrease in the other acyl-CoAs. Similar changes in acyl-CoA
composition have previously been reported in an adapted ACB1-deleted strain; however, this strain also exhibited a
2.5-fold increase in pool size, which could be part of the adaptation
mechanism (Schjerling et al., 1996
). It is interesting that
the acyl-chain composition of the acyl-CoA pool is very different from
that of the total fatty acid pool in both Y700pGAL1-ACB1 and
Y700. This indicates that the total fatty acid composition is not
determined by the availability of acyl-CoAs in the cellular acyl-CoA
pool or that the acyl-CoA esters for glycerolipid synthesis originate from a unique and different pool. Alternatively, the acyl-CoA transferases are saturated with the preferred substrates. This indicates that Acb1p is not required for all aspects of lipid synthesis
but rather for specialized functions. The identical steady-state
32P labeling and turnover of
32P-labeled PL species by wild type and
Y700pGAL1-ACB1 indicate that Acb1p is not required for
general glycerolipid synthesis. This is further supported by the
identical [3H]myo-inositiol
incorporation into PI and the identical turnover of this lipid in the
two strains.
Y700pGAL1-ACB1 contained, in contrast to the previous
reported Acb1p deletion strain, increased levels of unsaturated fatty acids in total lipids. This observation combined with the fact that
general glycerolipid synthesis is not affected by deletion of Acb1p
indicate that Ole1p can obtain its substrate by a different route than
from Acb1p, perhaps by a direct interaction with FAS. The
increased level of OLE1 mRNA might, therefore, explain the increased level of unsaturated fatty acid. Direct interaction of
enzymes with fatty acid synthetase has previously been shown for
thioesterase II in the termination of medium chain fatty acid synthesis
in rodents (Knudsen, 1979
; Mikkelsen et al., 1987
).
The most dramatic change in fatty acid composition was the strong reduction in C26:0 levels accompanied by a shift to shorter fatty acids, indicating a direct or indirect involvement of Acb1p in VLCFA synthesis. The fact that Acb1p does not bind VLCFA-CoAs (Figure 4) excludes the possibility that the protein is involved in transfer of VLCFA-CoA between Elo2p and Elo3p and in product removal from the elongases. This and the accumulation of the FAS end product (C18:0-CoA) suggest that Acb1p is involved in transport of de novo synthesized acyl-CoA from FAS to the elongase. Furthermore, deletion of ACB1 did not affect ELO2 and ELO3 mRNA levels (Gaigg, Neergaard, Schneiter, Hansen, Færgeman, Jensen, Andersen, Friis, Sandhoff, Schrøder, and Knudsen, unpublished results), which suggests that the observed reduction in VLCFA synthesis is not caused by a reduced activity of Elo2p and Elo3p.
The observation that depletion of Acb1p in the temperature-sensitive
mutant of ACC1, mtr7-1 (Schneiter et al., 1996
),
which exhibits reduced synthesis of C26:0 fatty acid already at
permissive temperature, results in lethality (Gaigg, Neergaard,
Schneiter, Hansen, Færgeman, Jensen, Andersen, Friis, Sandhoff,
Schrøder, and Knudsen, unpublished results) indicates that both
proteins are active in the same pathway. The reduced levels of C26:0
fatty acid in Y700pGAL1-ACB1 cannot be rescued by supplying
cells with exogenous fatty acids (C16:0), indicating that Acb1p is
required for elongation of both newly synthesized acyl-CoAs from FAS
and exogenous added palmitic acid (Gaigg, Neergaard, Schneiter, Hansen, Færgeman, Jensen, Andersen, Friis, Sandhoff, Schrøder, and Knudsen, unpublished results). The ability of Y700pGAL1-ACB1 to
synthesize low levels of C26:0 fatty acid suggests that there are other
pathways by which acyl-CoAs are transported to the elongating enzymes
than the Acb1p-dependent pathway. Alternatively, Acb1p is not required for VLCFA synthesis, leading to the suggestion that reduced synthesis of VLCFA is secondary to a decrease in synthesis of sphingolipids.
C26 fatty acids are mainly found in the ceramide moiety of sphingolipids, and reduced synthesis and turnover of ceramide and sphingolipid could therefore increase the pool of VLCFA-CoAs available and feedback inhibit further VLCFA synthesis. Sphingolipid synthesis could also be limited by the lack of palmitoyl-CoA for the initial step of PHS synthesis, which is also required for ceramide synthesis. This is unlikely to be the case because addition of PHS did not stimulate [3H]myo-inositol incorporation into sphingolipids during pulse labeling with [3H]myo-inositol. However, the retarded growth of the acb1 lcb1 double mutant at permissive temperature indicated a common defect in long chain base synthesis. Addition of fatty acids (C16:0) to the medium, however, partly re-established sphingolipid synthesis and partly restored the ratios of the three sphingolipid species in Y700pGAL1-ACB1 (Figures 5B and 6B). It is tempting to suggest that the stimulation of sphingolipid synthesis by C16:0 is achieved by an increased synthesis of C26 fatty acids. However, the fact that addition of C16:0 does not restore C26:0 fatty acid levels, yet rescues sphingolipid synthesis, makes it unlikely that it is a lack of VLCFAs that is rate limiting for sphingolipid synthesis.
Using well defined temperature-sensitive secretion mutants, Puoti
et al. (1991)
demonstrated that the biosynthesis of MIPC, M(IP)2C, and some IPC species is dependent on
genes required for vesicular transport of proteins from endoplasmic
reticulum (ER) to the Golgi apparatus.
Glycosylphosphatidylinositol (GPI)-anchored proteins are
inserted into ceramide/sphingolipid rafts already in the ER (Bagnat et al., 2000
), suggesting that GPI-anchored proteins and
sphingolipids are cotransported from the ER to the plasma membrane.
Strains carrying mutations in genes encoding proteins responsible for addition of GPI anchors to proteins also exhibit strongly reduced sphingolipid synthesis (Leidich et al., 1994
; Schonbachler
et al., 1995
). It has been shown that serine-palmitoyl
transferase (Lcb1p/Lcb2p) activity was reduced by 80% in these
strains. The authors suggested that the lack of addition of GPI anchors
prevented cotransport of sphingolipids and the GPI-anchored proteins
out of the ER, leading to accumulation of ceramide or IPC in the ER and
repression of Lcb1p and/or Lcb2p (Schonbachler et al.,
1995
).
BFA disassembles the Golgi apparatus and thereby blocks transport
between the ER and Golgi. Treatment of yeast with BFA caused growth
inhibition but did not affect incorporation of
[3H]inositol into total lipids
(sphingolipids and PI; Hechtberger and Daum, 1995
). The amount of label
incorporated into IPC and MIPC was dramatically reduced, whereas the
incorporation into M(IP)2C was unaffected, which
we also observed in Y700pGAL1-ACB1 in the present study. The
authors suggested that BFA disturbed the transport-linked metabolic
conversion of IPC to MIPC and that the Golgi synthesizes or contains
sufficient unlabeled MIPC to support continued
[3H]myo-inositol
incorporation into M(IP)2C.
The facts that sphingolipid synthesis is tightly coupled to vesicular
trafficking and that
[3H]myo-inositol labeling of
Y700pGAL1-ACB1 matches the labeling pattern in BFA-treated
cells indicate that the reduced sphingolipid synthesis in the
Acb1p-depleted strain is due to a decreased IPC turnover caused by
perturbed vesicular trafficking. This assumption is supported by the
facts that PHS did not stimulate
[3H]myo-inositol
incorporation into sphingolipids and that fatty acids did not stimulate
C26:0 synthesis. Furthermore, when the supply of VLCFA-CoAs for
ceramide synthesis is blocked by mutation in either ELO2 or
ELO3, a general reduction in the synthesis of all
sphingolipid species is observed (Oh et al., 1997
) and not IPC and MIPC alone, as seen in the Acb1p-depleted strain.
The relative level of IPC and MIPC in the plasma membrane is increased in the Acb1p-depleted strain, although the incorporation of [3H]myo-inositol into these two species is strongly reduced. This indicates that the reduced synthesis observed by [3H]myo-inositol labeling is caused by a reduced turnover of these lipids.
This hypothesis is supported by the reduced sphingolipid labeling and turn over in Y700pGAL1-ACB1 compared with wild type (Figure 6B). The accumulation of IPC and MIPC in the plasma membrane could indicate that trafficking of sphingolipids from the plasma membrane to the cell interior is abrogated.
This hypothesis is strongly supported by the observed accumulation of large amounts of differently sized vesicles, multilayer plasma membrane domains, autophagosomes or autophagocytotic/endosome-like bodies, and membrane fragment-containing vacuoles in Y700pGAL1-ACB1. These abnormalities indicate that Y700pGAL1-ACB1 has an abnormal membrane trafficking in general.
The electron microscopy studies suggest an increased autophagocytotic activity in Y700pGAL1-ACB1, presumably to cope with the accumulation of membrane material in the form of vesicles and abnormal plasma membrane structures. The above results strongly indicate that Acb1p plays an important role in transport-mediated lipid synthesis. The observation that Y700p GAL1-ACB1 also shows delayed maturation of a number of proteins, including amino peptidase 1 (Gaigg, Neergaard, Schneiter, Hansen, Færgeman, Jensen, Andersen, Friis, Sandhoff, Schrøder, and Knudsen, unpublished data), indicates that the role of Acb1p in trafficking is not limited to lipid/membrane trafficking at the plasma membrane level.
A requirement for long-chain acyl-CoA esters for budding and fusion of
vesicles was reported earlier (Glick and Rothman, 1987
; Pfanner
et al., 1989
, 1990
; Rothman and Wieland, 1996
). The addition of a thioether analogue of palmitoyl-CoA blocked both budding from ER
and fusion of ER-derived vesicles with Golgi membranes (Pfanner
et al., 1989
). Budding of synaptic-like microvesicles and
Golgi vesicles has recently been shown to require acyl-CoA for
conversion of LPA to PA, catalyzed by the lysophosphatidic acid
acyl-transferases endophilin and CtBP/BARS, respectively (Schmidt
et al., 1999
; Weigert et al., 1999
).
The fact that both the plasma membrane level of LPA is almost doubled and that the relative content of C16:0/C18:1-PA are significantly reduced in Y700pGAL1-ACB1 indicate that similar mechanisms may exist in yeast and that they depend on Acb1p.
ACBP/Acb1p binds acyl-CoA esters with very high affinity and is always
expressed at very high levels in secretory tissues of higher eukaryotes
(Færgeman and Knudsen, 1997
). This fact combined with the observed
defects in membrane trafficking in Y700pGAL1-ACB1 suggest a
role for Acb1p in delivery of acyl-CoA in these pathways.
Supplementation of palmitic acid can partly restore the transport phenotype, indicating that reduced availability of acyl-CoA for budding and fusion in Y700pGAL1-ACB1 can be overcome by acyl-CoA synthesized from exogenous fatty acids by the fatty acid-activating enzymes such as Faa1p and Faa4p.
In summary, the present results strongly indicate that Acb1p is not required for general glycerolipid synthesis but is necessary for normal synthesis of VLCFAs and that Acb1p plays an important role in transport-mediated lipid synthesis and membrane trafficking.
| |
ACKNOWLEDGMENTS |
|---|
We would like to thank the Center for Interaction, Structure, Function and Engineering of Macromolecules and The Carlsberg Foundation for financial support.
| |
FOOTNOTES |
|---|
These authors contributed equally to the
experimental work performed.
¶ Corresponding author. E-mail: jkk{at}bmb.sdu.dk.
| |
REFERENCES |
|---|
|
|
|---|